Vireo Systems, Inc.;Board of Regents of the University of Nebraska
发明人:
Donald W. Miller,Jonathan L. Vennerstrom,Mark C. Faulkner
申请号：
US15344835
公开号：
US20170049736A1
申请日:
2016.11.07
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention is directed to an oral supplement including creatine hydrochloride, which has an aqueous solubility that is at least 15 times greater than creatine monohydrate, where the oral supplement drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.
